Early stage COVID-19 disease dynamics in Germany: models and parameter identification
Thomas Götz1, Peter Heidrich1,2
1Mathematical Institute, University Koblenz-Landau, D-56070 Koblenz, Germany.
This study presents an extended SEIRD model to analyze coronavirus disease (COVID-19) dynamics in Germany. The model incorporates unidentified cases, improving predictions based on official data.
Area of Science:
- Epidemiology
- Mathematical Modeling
- Public Health
Background:
- The emergence of SARS-CoV-2 (COVID-19) in late 2019 necessitated robust data collection and analysis.
- International organizations like WHO and institutions such as Johns Hopkins University provide daily global COVID-19 case and fatality data.
- German Robert-Koch-Institute (RKI) data is crucial for national-level analysis but often lags behind international sources.
Purpose of the Study:
- To develop and present an extended SEIRD model for describing COVID-19 disease dynamics specifically within Germany.
- To calibrate the model parameters by aligning its output with officially reported COVID-19 cases in Germany.
- To enhance the model's accuracy by including an additional parameter that accounts for the impact of undetected infections.
Main Methods:
- Utilized an extended compartmental model (SEIRD) to simulate disease transmission.
- Calibrated model parameters using time-series data of officially reported COVID-19 cases in Germany.
- Integrated a parameter to represent the contribution of asymptomatic or unreported cases to the overall disease spread.
Main Results:
- The developed SEIRD model effectively describes COVID-19 disease dynamics in Germany.
- Parameter estimation allowed for a closer match between model predictions and official case reporting.
- The inclusion of a parameter for unidentified cases improved the model's ability to capture real-world disease spread.
Conclusions:
- The extended SEIRD model provides a valuable tool for understanding and predicting COVID-19 epidemiology in Germany.
- Accurate parameterization, including accounting for unidentified cases, is essential for reliable disease modeling.
- This approach can aid public health officials in Germany in their response to the COVID-19 pandemic.
More Related Videos
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
10:11Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
Related Concept Videos
Steps in Outbreak Investigation
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
Model Approaches for Pharmacokinetic Data: Physiological Models
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
